MT10109L in the Treatment of Glabellar Lines
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- SangMi Park
Medytox Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre de la Fontaine
Loverval, Hainaut, Belgium
- Medical Skin Care
Sint-Truiden, Limburg, Belgium
- Universitair Ziekenhuis Brussel
Brussels, Belgium
- Chu Liege
Liège, Belgium
- Kazan State Medical University
Kazan', Tatarstan Republic, Russia
- Medical Centre Capital-Zdorovie
Moscow, Russia
- Investigate Md
Scottsdale, Arizona, United States
- Art of Skin Md
Solana Beach, California, United States
- Weinkle Dermatology
Bradenton, Florida, United States
- Etre, Cosmetic Dermatology and Laser Center
New Orleans, Louisiana, United States
- Dermatology and Laser Surgery Center of New York
New York, New York, United States
- Skinsearch of Rochester, Inc.
Rochester, New York, United States
- M3 Wake Research, Inc.
Raleigh, North Carolina, United States
- Aventiv Research, Inc.
Dublin, Ohio, United States
- Westlake Dermatology & Cosmetic Surgery
Austin, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Dec 2018
- Primary completion
- 13 Mar 2020
- Completion
- 25 Jan 2021
- Last update posted
- 27 Jul 2023
- Registered enrollment
- 234
- Registry id
- NCT03795922
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.